Twist Bioscience Corp (TWST)
44.30
-0.38
(-0.84%)
USD |
NASDAQ |
May 07, 10:25
Twist Bioscience Research and Development Expense (Annual): 106.89M for Sept. 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 106.89M |
| September 30, 2022 | 120.31M |
| September 30, 2021 | 69.07M |
| September 30, 2020 | 43.01M |
| Date | Value |
|---|---|
| September 30, 2019 | 35.68M |
| September 30, 2018 | 20.35M |
| September 30, 2017 | 19.17M |
| September 30, 2016 | 18.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
35.68M
Minimum
2019
120.31M
Maximum
2022
74.99M
Average
69.07M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Tandem Diabetes Care Inc | 169.67M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |
| Asensus Surgical Inc | 37.02M |
| Catheter Precision Inc | 0.475M |